SCHEMBL7612164

SCHEMBL7612164

Cc1ccc(NC(=O)c2ccccc2-c2ccccc2)cc1C(=O)N(C)Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ LMNA P02545 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ TACR1 P25103 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ CHRNB2 P17787 1/20 0.48
▸ CHRNB4 P30926 1/20 0.48
▸ CHRNA3 P32297 1/20 0.48
▸ CHRNA4 P43681 1/20 0.48
▸ MTTP P55157 2/20 0.47
▸ HTT P42858 3/20 0.47
▸ GAA P10253 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ OPRL1 P41146 1/20 0.46
▸ MAPT P10636 1/20 0.45
▸ FFAR1 O14842 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605010 0.82 CHRNB2 (0.61) KMT2AALDH1A1LMNAL3MBTL1TP53
SCHEMBL7612267 0.78 MTTP (0.56) KMT2AALDH1A1MEN1L3MBTL1TACR1
SCHEMBL13329267 0.77 LMNA (0.78) KMT2AALDH1A1LMNAL3MBTL1TP53
SCHEMBL7607110 0.76 KMT2A (0.58) KMT2AALDH1A1MEN1TACR1
SCHEMBL7039015 0.74 MTTP (0.55) KMT2AALDH1A1MEN1TACR1MTTP
SCHEMBL7606350 0.73 MTTP (0.59) KMT2AALDH1A1MEN1TACR1TP53
SCHEMBL7607157 0.71 TP53 (0.65) KMT2AALDH1A1LMNAL3MBTL1TP53
SCHEMBL6794365 0.70 MTTP (0.55) TACR1MTTP
SCHEMBL10330504 0.70 KMT2A (1.00) KMT2AALDH1A1MEN1GAAMAPT
SCHEMBL6795782 0.69 FFAR1 (0.67) KMT2AALDH1A1MEN1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 KMT2A 2379/4885ALDH1A1 190/4885MEN1 4038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback